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IL-23-mediated mononuclear phagocyte crosstalk
protects mice from Citrobacter rodentium-induced
colon immunopathology
Tegest Aychek1, Alexander Mildner1, Simon Yona1, Ki-Wook Kim1, Nardy Lampl1, Shlomit Reich-Zeliger1,
Louis Boon2, Nir Yogev3, Ari Waisman3, Daniel J. Cua4 & Steffen Jung1
Gut homeostasis and mucosal immune defense rely on the differential contributions of
dendritic cells (DC) and macrophages. Here we show that colonic CX3CR1
þ mononuclear
phagocytes are critical inducers of the innate response to Citrobacter rodentium infection.
Speciﬁcally, the absence of IL-23 expression in macrophages or CD11bþ DC results in the
impairment of IL-22 production and in acute lethality. Highlighting immunopathology as a
death cause, infected animals are rescued by the neutralization of IL-12 or IFNg. Moreover,
mice are also protected when the CD103þ CD11b DC compartment is rendered deﬁcient
for IL-12 production. We show that IL-12 production by colonic CD103þ CD11b DC is
repressed by IL-23. Collectively, in addition to its role in inducing IL-22 production, macro-
phage-derived or CD103 CD11bþ DC-derived IL-23 is required to negatively control the
otherwise deleterious production of IL-12 by CD103þ CD11b DC. Impairment of this critical
mononuclear phagocyte crosstalk results in the generation of IFNg-producing former TH17
cells and fatal immunopathology.
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T
he intestinal lamina propria hosts a complex make-up of
mononuclear phagocytes, including dendritic cells
(DC) and macrophages that collectively contribute
to the maintenance of gut homeostasis and responses to
pathogen challenges1. Murine intestinal DC subpopulations are
currently deﬁned by the expression of integrins CD11c (aX),
CD11b (aM) and CD103 (aEb7), as well as CD24 (ref. 2).
CD103þ CD11b DC depend, like classical splenic XCR1þ
CD8aþ DC, on the transcription factors Irf8, Id2, and Batf3 for
their developmenton3. These cells migrate to the mesenteric
lymph nodes to prime and polarize naı¨ve T cells and seem as their
splenic counterpart specialized in cross-presentation4. In contrast,
CD103þ CD11bþ DC in the ileum were shown to be required
for the efﬁcient generation of Th17 cells5–8. In the colon,
CD103þ CD11bþ DC are rare, but might be functionally
replaced by a population lacking CD103 expression9. The
ontogeny of CD103þ and CD103 CD11bþ DC remains less
well deﬁned, as these cells are currently difﬁcult to discern from
monocyte-derived cells10. The most abundant intestinal
mononuclear phagocytes are CX3CR1hi macrophages that
develop from Ly6Cþ blood monocytes and are conditioned in
the healthy gut to become non-inﬂammatory cells11,12. In steady
state, these cells are non-migratory and are critically involved in
the maintenance of gut homeostasis13. Speciﬁc activities of
intestinal macrophages and the DC subsets, and in particular,
potential crosstalk between these cells remain incompletely
understood.
Attaching and effacing (A/E) enteropathogens adhere to
intestinal epithelial cells of the infected host, efface their
microvilli and reorganize their cytoskeleton. They control host
cells by the injection of effector molecules via a type III secretion
system, whose components are encoded on a conserved
pathogenicity island14. In immunocompetent mice, the A/E
pathogen Citrobacter rodentium, which serves as model organism
for human enteropathogenic Escherichia coli and entero-
haemorrhagic E. coli15, induces a transient, distal colitis
followed by a systemic CD4þ T-cell-dependent IgG response
resulting in bacterial clearance16. Mice deﬁcient in the cytokine
interleukin-23 (IL-23), a heterodimer of p19 and p40 polypeptide
chains encoded by the il23a and il12b genes, respectively17,
fail to control C. rodentium and die from the infection within a
week18. IL-23 requirement has been linked to IL-22 secretion by
RORgt-dependent innate lymphoid cell (ILC; now named group
3 ILC, or ILC3;ref. 19). Thus, C. rodentium-challenged
il23a-deﬁcient animals can be rescued by exogenous IL-22;
moreover, also IL-22-deﬁcient mice die from C. rodentium
infection, albeit with a delay20. IL-22 is believed to boost epithelial
regeneration and induces epithelial cells to express antimicrobial
peptides (AMPs), including defensins and lectins of the RegIII
family20,21.
Here we investigated the cellular source of early IL-23 that
protects Citrobacter-challenged mice. In line with recent reports,
we establish that IL-23 production by colonic CX3CR1þ
mononuclear phagocytes, including CD103 CD11bþ DC and
macrophages—but not CD103þ CD11b DC—was required for
the induction of IL-22 and AMPs. Animals harbouring an IL-23
deﬁciency acutely died from the Citrobacter challenge. Interest-
ingly though, mice could be rescued by an additional IL-12
deﬁciency in the CD103þ CD11b DC compartment, as well as
antibody-mediated neutralization of IL-12 and interferon-g
(IFNg). Collectively, we establish that IL-23, in addition to its
role as inducer of IL-22 and AMPs, suppresses IL-12 production
by colonic CD103þ CD11b DC. Impairment of this mono-
nuclear phagocyte crosstalk results in lethal immunopathology
that is associated with the generation of IFNg-producing TH1
cells from former TH17 cells.
Results
Haematopoietic IL-23 is essential to survive C. rodentium
infections. Host defense against C. rodentium involves the
orchestrated expression of cytokines and AMPs20. Kinetics of the
response can, however, considerably vary depending on the local
microbiota composition22. We therefore analysed the colonic
tissue isolated from Citrobacter-challenged C57BL/6 (wild-type)
WT mice housed in our animal facility for the expression of IL-12
superfamily cytokines, for example, IL-12 and IL-23, composed of
p35/p40 and p19/p40, respectively. We found the expression of
il23a (encoding IL23p19) to be transiently upregulated on day 3
post infection (PI), alongside il12b (encoding IL12p40), while
il12a (encoding IL12p35) was induced only by day 6 PI
(Supplementary Fig. 1a, Supplementary Table 1). As previously
reported20, the induction of IL-23 was followed by the production
of IL-22 and the AMP RegIIIb, as well as members of the S100A
family and IL-17A (Supplementary Fig. 1b,c). To probe the
requirement of a haematopoietic IL-23 source, we generated
chimeras by engrafting lethally irradiated WT mice with
either il12b- or il23a-deﬁcient bone marrow (BM) cells.
(il23a /4WT) chimeras died from the C. rodentium
challenge by day 12 PI; surprisingly though, (il12b /4WT)
BM chimeras mice survived (Fig. 1a). Both the chimeras
displayed an impaired induction of IL-22 and RegIIIb
transcripts, compared with controls (Fig. 1b). The absence of
these factors alone could hence not explain the differential
lethality. To determine whether BM chimeras harbouring the
il23a mutation succumb to the infection due to increased
pathogen burden, we took advantage of the bioluminescence of
the C. rodentium strain we used for the challenge23. The reporter
signal intensities emitted from chimeras lacking IL-23 or IL-12/23
production were comparable (Fig. 1c), arguing against bacterial
overload as the death cause. Challenged (il23a /4WT) and
(il12b /4WT) chimeras displayed reduced mucosal hyper-
plasia and goblet cell prevalence, as compared with (WT4WT)
controls. However, these alterations were comparable in the two
mutant groups (Fig. 1c). To gain further insight into the potential
mechanism underlying the differential lethality of the chimeras,
we measured cytokine levels in the supernatant of colon explant
cultures by enzyme-linked immunosorbent assay (ELISA).
Interestingly, samples of infected (il23a /4WT) but not
(WT4WT) chimeras displayed a signiﬁcant increase in IL-12,
which was as expected absent from the (il12b /4WT)
chimeras (Fig. 1d). On the other hand, IFNg levels were
increased in both (il23a /4WT) and (WT4WT) cultures,
but low in (il12b /4WT) cultures. Thus collectively, increased
IL-12 production in the colon correlates with lethality, as does
IFNg production, in absence of IL-22.
Of note, the fact that (il12b /4WT) chimeras survived the
C. rodentium challenge contrasts the reported lethality observed
for il12b / mice18. Indeed, also in our animal facility these
mice died from infection, as did (il12b /4il12b / ) BM
chimeras, while animals with p40-proﬁcient donor or recipient
genotype survived (Supplementary Fig. 2). This discrepancy
might be related to a radio-resistant long-lived p40-expressing
population or could result from the inherent difference between
mice that lack p40 throughout development versus chimeras
rendered p40 deﬁcient only in adulthood. While this ﬁnding
warrants further exploration, it does not affect our study as all
subsequent experiments were performed in BM chimeras and,
wherever possible, included internal controls.
Collectively, our data conﬁrm the earlier notion that
haematopoietic cells are a critical source of IL-23. Surprisingly
though, the resistance of (il12b /4WT) BM chimeras
to the C. rodentium challenge indicated that the IL-22 or
AMP deﬁciency alone are not responsible for acute death.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7525
2 NATURE COMMUNICATIONS | 6:6525 | DOI: 10.1038/ncomms7525 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Rather our data suggest that the lethality might be due to IL-12
overproduction.
CX3CR1þ cell-derived IL-23 is critical to survive C. rodentium
challenge. To further deﬁne the cell type that produces IL-23 in
the infected colon, we employed a conditional cell ablation
strategy targeting intestinal mononuclear phagocytes. CD11c-
DTR mice24 allow for diphtheria toxin (DTx)-induced
conditional ablation of the three major colonic mononuclear
phagocytes, including CD103þ CD11b DC, CD103
CD11bþ DC and CX3CR1hi macrophages25.
To investigate the impact of IL-23 production by DC
or macrophages on the anti-Citrobacter response, we took
advantage of a mixed BM chimera approach26 (Fig. 2a).
Speciﬁcally, we generated three groups of chimeras by
reconstituting WT mice with equal mixtures of DTR-transgenic
BM and mutant BM. Upon DTx treatment, such mixed
chimeras are left with mutant mononuclear phagocytes only,
while other cellular compartments remain composed of WT
and mutant cells. Flow cytometric analysis of DTx-treated
mixed BM chimeras conﬁrmed the speciﬁc ablation of DTR-
transgenic (CD45.1þ ) cells from the colon (Fig. 2b). DTx-treated
(il23a / /CD11c-DTR4WT) chimeras, retaining only IL-23-
deﬁcient CD11cþ cells, including all intestinal DC and
macrophages, died by day 8 PI (Fig. 2c). This establishes DC or
macrophages as critical IL-23 sources in the colon. Interestingly,
infected DTx-treated (il12b / /CD11c-DTR4WT) chimeras
survived and the combined absence of IL-23 and IL-12 thus
again conferred resistance to the challenge. Mice lacking either
IL-23- or IL-12/23-producing CD11cþ cells displayed a
signiﬁcant reduction in IL-22 transcripts in colonic tissue,
when compared with WT chimeras (Fig. 2d). None of the BM
chimeras exhibited a signiﬁcantly increased bacterial burden
(Supplementary Fig. 3a).
Taking advantage of CX3CR1Cre mice27, we next developed an
ablation strategy that spares CD103þCD11b DC. Flow
cytometric analysis of the ileum and colon of CX3CR1Cre:
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Figure 1 | Haematopoetic IL-23 is essential to survive C. rodentium infections. (a) Survival curves of C. rodentium-challenged (il12b /4WT),
(il23a /4WT) and (WT4WT) BM chimeras (n¼6 per group, representative of three individual experiments). (b) Real-time PCR analysis of IL-22 and
RegIIIb expression in colonic tissues collected on day 7 PI. All groups, as in a (n¼4–6 mice per group, representative of three individual experiments). Data
were analysed by analysis of variance (ANOVA) followed by Tukey’s post hoc test, **Po0.01. (c) Tissue distribution of the luminescent C. rodentium strain
at day 7. IVIS results are displayed as pseudo-colour images of peak bioluminescence, with variations in colour representing light intensity at a given
location; right panel quantiﬁcation of the luminescent C. rodentium signal. Lower panel, periodic acid-Schiff staining indicating goblet cell deletion, and
decreased mucosal hyperplasia in (il12b /4WT) and (il23a /4WT) chimeras. (n¼ 3–5 mice per group from three individual experiments). Data
were analysed by ANOVA followed by Tukey’s post hoc test, **Po0.01. (d) ELISA for IL-12 and INFg performed on supernatants of colon explant cultures of
C. rodentium-challenged (il12b /4WT), (il23a /4WT) and (WT4WT) BM chimeras on day 7 PI (n¼ 3–5 mice per group from three individual
experiments). Data were analysed by ANOVA followed by Tukey’s post hoc test, **Po0.01, ***Po0.001.
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R26-RFP reporter mice revealed that CD64þ CD11bþ
macrophages were, as expected, homogeneously labelled
(Supplementary Fig. 4a,b; Supplementary Fig. 5a,b); also
colonic CD103 CD11bþ DC showed frequent
rearrangements. Of note, ileal CD103þ CD11bþ DC were
found to be efﬁciently labelled in CX3CR1Cre:R26-RFP reporter
mice as well (Supplementary Fig. 5a,b); however, these cells are
rare in the colon (Supplementary Fig 4a,b). In contrast, few ileal
and colonic CD103þ CD11b DC showed signs of Cre
recombinase activity. After crossing CX3CR1Cre mice to iDTR
animals28, CX3CR1-expressing cells become sensitive to DTx.
CX3CR1Cre:iDTR (‘CX3CR1-DTR’) mice did not tolerate
prolonged ablation, but (CX3CR1-DTR4WT) BM chimeras
showed no adverse side effects of repetitive and prolonged DTx
treatment. Flow cytometric analysis of both the colon and the
ileum of DTx-injected CX3CR1-DTR chimeras revealed that—
consistent with the above reporter gene expression proﬁle—
intestinal macrophages were efﬁciently ablated (Supplementary
Fig. 4c–e; Supplementary Fig. 5c–e). In addition, colonic
CD103 CD11bþ cells and ileal CD103þ CD11bþ compart-
ments were signiﬁcantly affected. In contrast, intestinal CD103þ
CD11b DC were largely resistant to the ablation. In summary,
the CX3CR1Cre system spares (BatF3-dependent) CD103þ
CD11b DC, but targets both CX3CR1hi macrophages and
CD103þ and CD103 CD11bþ DC; the latter might be due to
their expression of the chemokine receptor or their derivation
from CX3CR1-expressing cells27. For simplicity we will refer from
here on to cells that are in CX3CR1-DTR mice sensitive to DTx as
‘CX3CR1þ cells’. In analogy to the above CD11c-DTR
experiment, we generated mixed chimeras with CX3CR1-DTR
BM and either mutant or WT BM, and challenged the animals
with C. rodentium. Mice that after DTx treatment speciﬁcally
lacked il23a in their CX3CR1þ cell compartment died by day 10–
12 after infection (Fig. 2e). Furthermore, also mice that lacked
il12b in CX3CR1þ cells, impairing both their IL-12 and IL-23
production, died. Both the groups of animals displayed a
considerable reduction in IL-22 and RegIIIb transcripts, when
compared with WT chimeras (Fig. 2f). These data establish that
the production of the colonic IL-23, which induces IL-22 and
AMPs in response to the C. rodentium challenge is restricted to
CD103 CD11bþ DC or macrophages, but not CD103þ
CD11b DC. Our data thus support previous reports of IL-23
expression by these cells or their equivalents8,29–31. Importantly,
the fact that DTx-treated (il12b / /CX3CR1-DTR4WT)
chimeras die from the Citrobacter challenge, but (il12b / /
CD11c-DTR4WT) chimeras survive, indicates that the rescue
results from the introduction of the IL-12 deﬁciency into the
CD103þ CD11b DC compartment. These data support our
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Figure 2 | IL-23 production by colonic macrophages and CD103 CD11bþ DC is required to survive the C. rodentium challenge. (a) Schematic of mixed
BM chimera approach. (b) Flow cytometric analysis of colon of DTx-injected mouse on day 5 after DTX treatment (lower panel) and control (upper panel)
showing the depletion of CD11cþ CD45.1þ DTR-transgenic cells. Data represent one of the three independent experiments (n¼ 3 mice per group).
(c) Survival curves of DTx-treated (il23a / /CD11c-DTR4WT), (il12b / /CD11c-DTR4WT) and (WT/CD11c-DTR4WT) chimeras following
Citrobacter challenge (n¼ 6 per group from three individual experiments). (d) Real-time PCR analysis of IL-22 expression in colonic tissues collected from
DTx-treated (il23a / /CD11c-DTR4WT), (il12b / /CD11c-DTR4WT) and (WT/CD11c-DTR4WT) chimeras on day 7 PI (n¼4–6 per group from
three individual experiments). Data were analysed by analysis of variance (ANOVA) followed by Tukey’s post hoc test, **Po0.01. (e) Survival curves
of DTx-treated (il23a / /CX3CR1-DTR4WT), (il12b // CX3CR1-DTR4WT) and (WT/CX3CR1-DTR4WT) chimeras following Citrobacter challenge
(n¼ 7 per group from three individual experiments). (f) Real-time PCR analysis for IL-22 and RegIIIb expression of colonic tissues collected from
DTx-treated (il23a // CX3CR1-DTR4WT), (il12b // CX3CR1-DTR4WT) and (WT/CX3CR1-DTR4WT) chimeras on day 8 PI (n¼ 5 per group from
three individual experiments). Data were analysed by ANOVA followed by Tukey’s post hoc test *Po0.05, ***Po0.001. w/o, without.
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earlier observation that exacerbated IL-12 production by
CD103þ CD11b DC is associated with the lethality in our
system (Fig. 1d).
IL-23 regulates IL-12 production by CD103þ CD11b DC. To
directly deﬁne the cells that express IL-12 and IL-23 before and
after C. rodentium challenge in vivo, we performed an reverse
transcription PCR expression analysis on ﬂuorescence-activated
cell sorting (FACS)-sorted cells (Supplementary Fig. 6a,b).
Colonic CD11cþ CD64þ CD24þ macrophages, but neither
CD103þ CD11b DC nor CD103 CD11bþ DC responded to
the infection with il23a induction (Fig. 3a). CD103þ CD11b
DC, on the other hand, downregulated il12a mRNA expression.
Interestingly, CD103þ CD11b DC, but not CD103 CD11bþ
DC seem to express the IL-23 receptor, as they displayed signals
for both il23r and il12rb1 (Fig. 3a, Supplementary Fig. 6c) thus
sensitizing these cells to IL-23. To examine whether the presence
or absence of IL-23 expression from CX3CR1þ cells affects IL-12
production by CD103þ CD11b DC, we sorted these cells from
infected DTx-treated (il23a / /CX3CR1-DTR4WT) chimeras
and compared them with cells isolated from infected DTx-treated
control chimeras. In the absence of CX3CR1þ cell-derived IL-23,
CD103þ CD11b DC displayed signiﬁcantly enhanced il12a
and il12b mRNA expression, whereas il12a mRNA expression by
macrophages was unaffected (Fig. 3b).
These data suggest that CD103þCD11b DC are subject to
IL-23-dependent paracrine negative control. Speciﬁcally, colonic
CX3CR1þ cells, including macrophages and possibly CD103
CD11bþ DC produce IL-23 that suppresses IL-12 expression by
CD103þ CD11b DC. To directly investigate this putative
negative control circuit, we generated mixed chimeras with WT
and il-23rgfp/gfp BM32. The resulting mice harbour in their
lamina propria both IL23R-deﬁcient (CD45.2þ ) and -proﬁcient
(CD45.1þ ) CD103þ CD11b DC (Fig. 4a). We then challenged
these mice with C. rodentium. Conﬁrming the genotype of the
BM grafts IL23R expression was absent from CD45.2þ CD103þ
CD11b DC as compared with the CD45.1þ WT DC
equivalents (Fig. 4b). More importantly though and proving
that CD103þCD11b DC are in the infected mice under
negative control by IL-23, IL23R-deﬁcient DC expressed
signiﬁcantly more il12a mRNA than WT DC isolated from the
same animals (Fig. 4b). In further support of the critical role of
IL-23 in controlling IL-12 production, supernatants of cultured
colon explants of Citrobacter-infected (il23r gfp/gfp4WT) mice
showed signiﬁcantly higher IL-12 levels than that of infected
controls (Fig. 4c). Collectively, this establishes that intestinal
CD103þCD11b DC are target of a critical IL-23-mediated
negative control circuit that prevents overt and potentially
deleterious IL-12 production by these cells.
IL-23 is required to prevent IFNc-driven immunopathology.
C. rodentium-infected animals harbouring IL-23-deﬁcient
CX3CR1þ cells acutely succumb to infection. The above data
suggest that IL-23 controls otherwise deleterious IL-12 produc-
tion by CD103þ CD11b DC. IL-12 is known to promote the
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Figure 3 | Analysis of intestinal mononuclear phagocytes for basal and PI
cytokine production. (a) Reverse transcription PCR (RT–PCR) analysis of
FACS-sorted lamina propria DC and macrophages isolated from uninfected
or infected WTmice 3 days PI. Data are representative of 3–6 independent
experiments with DC and macrophages pooled from 7–10 mice (for sorting
strategy see Supplementary Fig. 6). (b) RT–PCR analysis of CD103þ
CD11b CD11cþ DC and CD103 CD11bþ CD11cþ cells, including
macrophages and CD103 CD11bþ DC were sorted from DTx-treated
mixed (WT/CX3CR1-DTR4WT) and (il23a //CX3CR1-DTR4WT) BM
chimeras. Data are presented as fold increase compared with the DC from
uninfected mice. Data were obtained from three independent experiments
with cells pooled from 9–11 chimeras. Data were analysed by two-tailed
t-test *Po0.05. TBP, TATA binding protein.
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polarization of naı¨ve T cells into TH1 cells and induce IFNg
secretion by CD4þ and CD8þ T cells, as well as NK cells that
can cause detrimental immunopathology33. To investigate
whether the uncontrolled IL-12 production by colonic CD103þ
CD11b DC triggers such a cascade in our system, we
neutralized IFNg in Citrobacter-infected mice that harbour IL-
23-deﬁcient CX3CR1þ cells using an antibody regimen. Indeed,
this treatment efﬁciently rescued infected DTx-treated (CD11c-
DTR/il23a /4WT) and (CX3CR1-DTR/il23a /4WT)
chimeras from pathogen-induced mortality (Fig. 5a,b).
Moreover, also the neutralization of IL12p40, that is, the
cytokine which is likely involved in the induction of IFNg33,
improved the survival of the respective Citrobacter-infected
animals (Fig. 5a,b).
The kinetics of the observed fatality suggested ILC or a pre-
existing T-cell population as IFNg—source. Fate-mapping studies
recently established that TH17 cells can differentiate into
pathogenic TH1 cells, both in the brain and gut34–36. To
evaluate the involvement of this TH17/TH1 cell axis in the
Citrobacter-infected mice lacking either IL-23 or IL-12/-23, we
analysed colonic tissue of whole and mixed BM chimeras
generated with il23a / , il12b / , CD11c-DTR and WT BM
cells. FACS analysis of T cells isolated from the colon of the
various mice, as well as reverse transcription PCR analysis for IL-
17A and IFNg expression indicated a shift towards TH1 cells in
IL-23-deﬁcient BM chimeras ((il23a /4WT); Fig. 5c). Similar
results were obtained when the IL-23 deﬁciency was restricted
to CD103 CD11bþDC and macrophages (DTx-treated
(il23a / /CD11c-DTR4WT) chimeras; Fig. 5d). To probe if
the observed accumulating TH1 cells derive from TH17 cells, we
analysed their CD121a (IL1R1) expression, which has been
reported to identify ‘exTH17 cells’ (ref. 35). As shown in Fig. 5e,
CD121a was prominently displayed on a fraction of IFNgþ TH1
cells isolated from mice lacking CX3CR1þ cell-derived IL-23. Of
note, IFNg transcript levels and TH1 frequencies were also
elevated in WT chimeras; however, these cells did not display
CD121a expression and were resistant to the infection.
Collectively, these data suggest that TH17-derived TH1 cells,
rather than conventional TH1 cells, are the source of the
deleterious IFNg that causes the severe immunopathology in the
absence of the IL-23-mediated mononuclear phagocyte crosstalk.
Discussion
The aim of this study was to deﬁne the differential contributions
of the intestinal DC and macrophages in the immediate early
innate host defense against C. rodentium challenge. Speciﬁcally,
we identiﬁed colonic CX3CR1þ mononuclear phagocytes,
including CD103 CD11bþ DC and macrophages, as early
producers of the critical IL-23 required for the induction of IL-22
and AMPs20. Absence of IL-23, however, not only impaired the
innate response, but also revealed the existence of a critical
crosstalk between colonic CX3CR1þ cells and CD103þ CD11b
DC. Speciﬁcally, we found that IL-23 suppressed IL-12
production by CD103þ CD11b DC thereby preventing fatal
immunopathology.
The host response to the A/E mouse pathogen C. rodentium
can be segregated into early innate reactions and late adaptive
immunity37. The former depend critically on IL-23, that is
required to induce IL-22 production by ILC3 (refs 20,38).
Notch2-dependent small intestinal CD11bþ CD103þ cells, the
likely equivalent of colonic CD103 CD11bþ DC, were shown
to produce IL-23 upon Citrobacter infection30. Moreover, these
IRF4-dependent cells were reported as the IL-23 source that
maintains the steady-state TH17 compartment in this tissue6–8.
Recent studies further established intestinal macrophages as the
IL-23 source31. We corroborate these ﬁndings by showing that
mice that harbour an IL-23 deﬁciency in colonic CX3CR1þ
mononuclear phagocytes, comprising CD103 CD11bþ DC and
macrophages, fail to induce IL-22 and AMPs.
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Surprisingly, Citrobacter-infected animals bearing only an IL-23
(p19) deﬁciency in all the DCs and macrophages died from the
bacterial challenge, whereas animals harbouring a combined IL-12/
23 (p40) deﬁciency were resistant, although both the mice display
impaired IL-22 induction. Furthermore, animals with an IL-12/23
mutation restricted to CX3CR1þ cells succumbed to the infection.
Collectively, these data suggested a critical deleterious role of
CD103þ CD11b DC-derived IL-12 and ensuing immunopathol-
ogy as cause of the acute death of the animals. Indeed, antibody-
mediated neutralization of IL-12 or IFNg rescued Citrobacter-
challenged mice harbouring the IL-23 deﬁciency.
Aside from orchestrating the early innate host response to
Citrobacter infection, that is, IL-22 and AMP induction, IL-23 is
thus also critically involved in a crosstalk of CX3CR1 cells and
neighbouring CD103þ CD11b DC. Our conclusion is
supported by the fact that (1) CD103þ CD11b DC express
IL-23 receptor and seem within the colonic DC compartment to
be uniquely sensitive to IL-23; (2) in absence of IL-23, IL12p35
and IL12p40 mRNA expression is signiﬁcantly increased in
CD103þ CD11b DC of Citrobacter-challenged mice, as was IL-
12 secretion by colon explants. Most importantly, (3) IL-23
receptor-deﬁcient CD103þ CD11b DC displayed prominent
IL12p35 mRNA expression over WT DC in the same Citrobacter-
challenged mice. The fact that IL-23 can interfere with the IL-12
axis has been previously reported in refs 39,40. Sieve et al.40
showed that IL-23 could inhibit the IL-12-induced effector
function of IFNg induction by T cells. However the authors
argued that this effect was due to a direct antagonistic IL-23 effect
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on the IL-12 receptor on T cells, rather than an IL23R-mediated
effect on IL-12 production by myeloid cells, as shown in this
study. Becker et al.39 showed that in an in vitro system IL-23
speciﬁcally downregulated IL-12 secretion in LPS-exposed BM
culture-derived DC. Focusing on IL23p19-deﬁcient DC, these
authors concluded that they observed an autocrine regulatory
loop, which they considered responsible for the aggravated colitis
observed in IL23p19 / mice39. Our present data support the
notion of such a less appreciated, but clinically probably highly
relevant immunoregulatory role of IL-23. Moreover importantly,
we extend the earlier reports by revealing a novel paracrine
regulatory circuit between the speciﬁc intestinal mononuclear
phagocyte subsets. Of note, this immunoregulatory role is distinct
from reported effects of IL-23 on IL-12 receptor signalling in T
cells, which limits their IFNg production40. The molecular details
underlying the suppressive effect of IL-23 on CD103þ CD11b
DC might be related to activation of signal transducer and
activator of transcription 3 (STAT3) and thus similar to IL-10
suppression of IL-12 production41. However, the exact
mechanism remains to be deﬁned.
IL-12 is known to polarize naı¨ve T cells towards a TH1 fate42.
However, given the short time frame of our experiments, the
immunopathology that we observed was unlikely to result from
exacerbated adaptive immunity. TH17 cells have been shown to
retain plasticity and can under certain pathological conditions,
such as experimental autoimmune encephalomyelitis34,35, but
also following Helicobacter challenge in the intestine36 convert
into TH1 cells. Given the presence of TH17 cells in the steady-
state colon, we considered these rapidly generated ‘exTH17’ TH1
cells an attractive explanation for the IFNg pathology we observe.
Indeed, we found TH1 cells in our setting of immunopathology to
express CD121a (IL1R1) indicative of their TH17 past35.
However, we cannot include the involvement of other IL-12
responsive IFNg producers, such as ILC-1 (ref. 43), or additional
direct IL-23 effects on ILC (ref. 44).
Intestinal homeostasis and gut resistance to pathogen challenge
rely on a balance of pro- and anti-inﬂammatory processes. This
‘homeostastic inﬂammation’ is established in response to the
constant microbial product exposure of this unique organ45. Our
ﬁndings highlight the interplay of these processes by
corroborating the role of myeloid cell-derived IL-23 as an
inducer of IL-22, which is known to promote mucosal healing
and stabilize barrier integrity. Importantly though, our data
indicate that IL-23 curbs the simultaneously potential damaging
immunopathology caused by IL-12 production. Of note, our data
do not argue against the importance of IL-22 in the protection
against Citrobacter challenge, which is well documented18,20.
However, we show that under certain conditions, such as the
absence of IL-12 production by CD103þ CD11bDC,
Citrobacter-challenged mice can handle an impaired IL-22
response, probably since epithelial injury is less severe.
Genome-wide association studies have revealed a link between
allelic variants of the IL-23 receptor, its signalling and the risk to
develop Crohn’s disease or ulcerative colitis, although the
underlying mechanistic details remain to be elucidated46,47.
Given the appreciated role of IL-23 in the control of ILC3 and
TH17 biology, efforts to understand the reason for genetic IBD
predispositions are currently largely focused on the effect of this
cytokine on innate and adaptive lymphocytes. Though not
mutually exclusive, our results suggest that the IL-23 receptor
variants could also affect a critical regulatory circuit between
myeloid cells that—when disrupted—might result in deleterious
hyperactivity of intestinal DC. Our results highlight the intricacy
of the regulatory circuits that exist in the intestinal lamina propria
to maintain immune protection and prevent collateral damage.
Moreover, these ﬁndings should be of clinical importance
highlighting a previously under-appreciated immunoregulatory
role of IL-23 on mononuclear phagocytes.
Methods
Mice. This study involved the use of the following mice, all on C57BL/6 back-
ground: B6.129S1-Il12btm/Jm/J mice (p40 / )48 and B6.IL23p19tm (p19 / )
mice49; CX3CR1Cremice27 (deposited at the European Mouse Mutant
Archive,EM:06349; JAX Stock No. 25524 B6.C-Cx3cr1otm1.1(cre)Jung4/J);
Rosa26-DTR (iDTR)28; CD11c-DTR mice24;IL-23Rgfp mice32. To analyse
recombinase activity of Cx3cr1cre mice the animals were crossed with Rosa-26-rfp
(ref. 50).For BM chimera generation, C57BL/6 mice were lethally irradiated with
950 rad. The next day, 5 106 BM cells isolated from the femora and tibiae of donor
mice were intravenously injected into the irradiated recipient mice, which were kept
at rest for 6–8 weeks before the experiment. Animals were maintained under speciﬁc
pathogen-free conditions and handled according to the protocols approved by the
Weizmann Institute Animal Care Committee as per international guidelines.
Citrobacter infection and assessment of bacterial load. Mice were gavaged with
a spontaneous naladixic acid-resistant derivative of the strain C. rodentiumICC168
(Citrobacter freundii biotype 4280), that is kanamycin-resistant and biolumines-
cent, the strain ICC180 (ref. 23), a kind gift of Gad Fraenkel (Centre for Molecular
Bacteriology and Infection, Division of Cell and Molecular Biology, Imperial
College London, London, United Kingdom). Mice were gavaged with 0.2ml of PBS
containing 109 c.f.u. Bacteria were grown at 37 C in Luria Bertani broth or on
Luria Bertani agar with kanamycin (50 mgml 1) After 3 h the bacterial density was
assessed by measuring its absorbance at an optical density of 600 nm and
conﬁrmed by plating of serial dilutions. For the assessment of bacterial load, mice
were anaesthetized and imaged using IVIS (Xenogen, Almeda, CA). Greyscale
reference images taken under low illumination were collected and overlaid with
images capturing the emission of photons from the bioluminescent C. rodentium
using LIVING IMAGE software (Xenogen). For the analysis of the colon, mice
were euthanized and imaged as above.
Cell preparations. For isolation of lamina propria DC and macrophages, intestinal
epithelial cells were removed by incubation with the HBSS containing DTT and 5%
of fetal calf serum and shaking in a 37 C incubator (300 r.p.m.) for 40min.
Intestinal pieces were digested in 5ml HBSS containing 10% FBS, 1.2mgml 1 of
collagenase VIII (Sigma) and shook (300 r.p.m.) at 37 C for 40min. Digested
colon tissue was passed through a 80-mm mesh and cells were collected by cen-
trifugation at 1,400 r.p.m. for 10min at 4 C. For isolation of intestinal T cells,
lamina propria cells were after the Collagenase digest fractionated on a Percoll
density gradient (40 and 80%). To allow for the intracellular cytokine staining of
TH17 cells and TH1 cells, IL-17A and IFNg production was triggered and accu-
mulated by PMA and ionomycin (Sigma) treatment for 2 h and treatment with
Brefeldin A and Monensin (eBioscience) for 2 h at 37 C 5% CO2. Cells were
permeabilized and ﬁxed for the intracellular staining by the BD perm/ﬁxation kit.
Antibody-mediated cytokine neutralization. For the neutralization experiments,
indicated mice were intraperitoneally injected with anti-IFNg-speciﬁc mAb (Clone,
XMG1.2) or anti-IL12p40-speciﬁc mAb (C17.8) on day 0, 2, 4, 6 and 8 after C.
rodentium infection at a dose of 1mg per mouse. The control groups received
isotype control IgG2a mAb.
Cell ablation. For cell depletion in (CX3CR1-DTR4WT) BM chimeras, 25 ng g 1
body weight diphtheria toxin (DTx; Sigma-Aldrich) was injected IP every 48 h for 5
days and the mice were euthanized 18–20 h after DTx injection. For prolonged cell
ablation in the functional assays, the dose was reduced to 12.5 ng g 1 body weight
after the ﬁrst 5 days (day  1 was one day before infection). (CD11c-DTR4WT)
BM chimeras were injected 12.5 ng g 1 in the ﬁrst 5 days and 6.25 ng g 1 body
weight until the end of the assay.
cDNA synthesis and real-time PCR. Total RNA was extracted from the colon
using the Gentle-MACS (MiltenyiBiotec) and RNA tissue kit (5prime) and from
the sorted cells with the RNeasy Micro Kit (Qiagen). cDNA synthesis was per-
formed with 0.5—2 mg of total RNA with High Capacity RNA-to-cDNA Kit
(Applied Biosystems). Real-time PCR was performed with SYBR Green master mix
(Applied Biosystems). Expression of each target gene was normalized to that of
TATA binding protein using the comparative (DDCT) method.
Histology. Tissues were ﬁxed in 4% paraformaldehyde overnight at 4 C,
embedded in parafﬁn, sectioned and stained with periodic acid-Schiff. Slides were
evaluated using an Olympus BX51 microscope, and image acquisition was con-
ducted with the Olympus DP70 camera and DP-Manager software. The percent
area of goblet cells and colonic hyperplasia were calculated using a technique
established previously51.
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Flow cytometric analysis. The following ﬂuorochrome-labelled monoclonal
antibodies and staining reagents were used according to manufacturer’s protocols:
lamina propria cells were stained with anti-CD11c-APC, anti-CD64-APC
(eBioscience), anti-CD11b-PerCP Cy5.5 (Biolegend), anti-CD103-PE/Horizon
421(BD Pharmingen), anti-MHC II-PE-CY7, anti-CD24- PE-CY7 (eBioscience),
anti-CD45.2-FITC (eBioscience), anti-CD45.1-Paciﬁc blue (Biolegend) and 40 ,6-
diamidino-2-phenylindole. TH17 and TH1 cells were stained with anti-IL-17A-PE,
anti-CD3-biotin, SA-PerCP, anti-CD4-APC, anti-CD8-FITC, anti-CD45-Paciﬁc
Blue anti-IFNg-PE-CY7 and anti-CD121A-PE. The cells were analysed with LSR
Fortessa ﬂow cytometer (BD) or sorted with a FACSAria machine (BD). Flow
cytometry analysis was done with the FlowJo software.
Analysis of colon explant cultures and ELISA. The colons of mice were ﬂushed
with RPMI and open along a longitudinal axis. Thereafter, 3-mm2 punch biopsies
were obtained from the distal colon and incubated for 24 h in RPMI supplemented
with 10% fetal calf serum and antibiotics (one punch biopsy per 100ml medium).
Supernatants were collected and kept frozen until assessed. Quantitative evaluation
of IL-12 and IFNg levels in supernatant were done using an ELISA modiﬁcation,
with spectrally distinguishable beads (Spherotech) as solid phase. Primary
antibodies were covalently linked to the beads, with spectrally different beads
linked to antibodies against a unique analyte. The various coated beads were
incubated simultaneously with the supernatant and secondary biotinylated
antibodies for 2 h, washed and stained with streptavidin-PE. Bead ﬂuorescence
level was used to separate the different analytes and then compared with a
standard curve for quantiﬁcation. The beads were analysed with LSRFortessa ﬂow
cytometer (BD).
Statistical analysis. Data were analysed by analysis of variance followed by
Tukey’s post hoc, two-tailed t-test, and long-rank analysis on the Kaplan–Meier
plots using GraphPad Prism 4 (San Diego, CA). Data are presented as mean±-
s.e.m. values of Po0.05 were considered statistically signiﬁcant. *Po0.05,
**Po0.01, ***Po0.001.
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